特应性湿疹治疗(TREAT)登记工作组:一项国际德尔菲研究,旨在确定国家特应性湿疹光疗和系统治疗登记的核心领域和领域条目
TREAT登记工作组采用三轮电子德尔菲法,纳入来自36个国家的479名参与者(医生、护士、非临床研究者、患者、企业及监管机构代表),就特应性湿疹研究登记应测量的核心领域和条目寻求国际共识。最终共识会议(42人参加)确立了包含19个领域、69个条目(49个基线条目和20个随访条目)的核心集,旨在标准化数据收集、促进跨国登记数据汇总,并为光疗和系统免疫调节治疗的有效性、安全性和成本效果提供洞见。
要点
- 三轮电子德尔菲法参与者来自36个国家,第1、2、3轮完成率分别为86%、79%和74%。
- 最终共识会议确立核心集含19个领域、69个条目(49个基线条目和20个随访条目)。
- 该核心集用于国家特应性湿疹系统治疗登记,以标准化数据收集并促进跨国数据汇总。
核心结论
- 国家特应性湿疹系统治疗登记应采集的核心领域和条目集将标准化数据收集,从而使登记之间可直接比较并促进国家间数据汇总。
研究设计与样本
- TREAT登记工作组采用德尔菲法,参与者来自医生、护士、非临床研究者、患者、企业和监管机构代表六个利益相关组。
- 电子德尔菲包括三轮连续在线调查,要求参与者对每个拟议领域条目的重要性进行评分,第1轮参与者可向拟议列表添加领域条目。
- 举行最终共识会议以批准核心集,参会者42人。
主要发现
- 来自36个国家的479名参与者访问了电子德尔菲平台,第1、2、3轮完成率分别为86%、79%和74%。
- 最终共识会议确立的核心集包含19个领域、69个领域条目(49个基线条目和20个随访条目)。
关键数值与推荐
- 核心集包含19个领域和69个领域条目,其中49个为基线条目、20个为随访条目。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Evidence of immunomodulatory therapies to guide clinical management of atopic eczema (AE) is scarce, despite frequent and often off-label use. Patient registries provide valuable evidence for the effects of treatments under real-world conditions that can inform treatment guidelines, give the opportunity for health economic evaluation and the evaluation of quality of care, as well as pharmacogenetic and dynamic research, which cannot be adequately addressed in clinical trials. OBJECTIVES: The TREatment of ATopic eczema (TREAT) Registry Taskforce aims to seek international consensus on a core set of domains and items ('what to measure') for AE research registries, using a Delphi approach. METHODS: Participants from six stakeholder groups were included: doctors, nurses, nonclinical researchers, patients, industry and regulatory body representatives. The eDelphi comprised three sequential online rounds, requesting participants to rate the importance of each proposed domain item. Participants could add domain items to the proposed list in round 1. A final consensus meeting was held to ratify the core set. RESULTS: Participants (n = 479) from 36 countries accessed the eDelphi platform, of whom 86%, 79% and 74% completed rounds 1, 2 and 3, respectively. At the face-to-face consensus meeting attended by 42 participants the final core set was established containing 19 domains with 69 domain items (49 baseline and 20 follow-up items). CONCLUSIONS: This core set of domains and items to be captured by national AE systemic therapy registries will standardize data collection and thereby allow direct comparability across registries and facilitate data pooling between countries. Ultimately, it will provide greater insight into the effectiveness, safety and cost-effectiveness of photo- and systemic immunomodulatory therapies.
引用
- Gerbens LAA, Apfelbacher CJ, Irvine AD, et al. TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo- and systemic therapy registries. Br J Dermatol. 2018. PMID: 29761486. doi:10.1111/bjd.16714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。